On March 31, 2020, Nexien BioPharma, Inc. announced that Alex Wasyl resigned as the chief executive officer and a director of the company due to personal reasons. Richard Greenberg, one of the founders of the company and an existing director, will serve as interim chief executive officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0164 USD | -21.90% | -21.90% | -36.68% |
1st Jan change | Capi. | |
---|---|---|
-36.68% | 1.42M | |
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |
- Stock Market
- Equities
- NXEN Stock
- News Nexien BioPharma, Inc.
- Nexien BioPharma, Inc. Announces Management Changes